Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrase type II (CA II) is a zinc-containing enzyme that catalyzes the reversible hydration of carbon dioxide to bicarbonate and protons. It plays a crucial role in pH regulation and CO₂ transport in various tissues. Deficiency or mutations in CA II are associated with carbonic anhydrase II deficiency syndrome, characterized by osteopetrosis, renal tubular acidosis, and cerebral calcification. CA II is also a therapeutic target in glaucoma, hypertension, and other diseases.
Inhibition of carbonic anhydrase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic anhydrase type II (CA II).